FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets
Recalling firm: Confidence Inc./Confidence U.S.A. Inc.
Why it was recalled
Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin
The exact product
FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7
Check the codes
Compare these FDA-provided codes, lot numbers or dates with the product you have.
Match the product, size and code together. A similar name alone does not identify your batch.
Original FDA code information
Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
| Type | Code / value | Context |
|---|---|---|
| UPC | 810891022537 | mine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7 |
| lot | 010216 | Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817 |
| lot | 070816 | Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817 |
| lot | 090117 | Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817 |
| lot | 100817 | Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817 |
Recall details
- Recall number
- F-1813-2018
- Event ID
- 80620
- FDA status
- Terminated
- Initiated
- Jul 26, 2018
- Reported
- Aug 22, 2018
- Classified
- Aug 13, 2018
- Terminated
- Oct 22, 2019
- Quantity
- 5,650 bottles in US distribution (total for all products)
- Location
- Port Washington, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Nationwide
FDA source record · F-1813-2018
Data updated September 16, 2026. View official FDA data ↗
A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.